Source:http://linkedlifedata.com/resource/pubmed/id/21353569
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2011-3-14
|
pubmed:abstractText |
Xanthine oxidase is a complex molybdoflavoprotein that catalyses the hydroxylation of xanthine to uric acid. Fifty three analogues of 1-acetyl-3,5-diaryl-4,5-dihydro(1H)pyrazoles were rationally designed and synthesized and evaluated for in vitro xanthine oxidase inhibitory activity for the first time. Some notions about structure activity relationships are presented. Six compounds 41, 42, 44, 46, 55 and 59 were found to be most active against XO with IC(50) ranging from 5.3 ?M to 15.2 ?M. The compound 59 emerged as the most potent XO inhibitor (IC(50)=5.3 ?M). Some of the important interactions of 59 with the amino acid residues of active site of XO have been figured out by molecular modeling.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1464-3391
|
pubmed:author |
pubmed-author:AgarwalAmitA,
pubmed-author:BanerjeeUttam CUC,
pubmed-author:DharK LKL,
pubmed-author:GuptaManish KMK,
pubmed-author:KumarRajR,
pubmed-author:NepaliKunalK,
pubmed-author:SapraSameerS,
pubmed-author:SattiNaresh KNK,
pubmed-author:SinghGurinderdeepG,
pubmed-author:SuriOm POP,
pubmed-author:TuranAnilA,
pubmed-author:VermaPrabhakar KPK
|
pubmed:copyrightInfo |
Copyright © 2011 Elsevier Ltd. All rights reserved.
|
pubmed:issnType |
Electronic
|
pubmed:day |
15
|
pubmed:volume |
19
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1950-8
|
pubmed:meshHeading |
pubmed-meshheading:21353569-Binding Sites,
pubmed-meshheading:21353569-Catalytic Domain,
pubmed-meshheading:21353569-Computer Simulation,
pubmed-meshheading:21353569-Drug Design,
pubmed-meshheading:21353569-Enzyme Inhibitors,
pubmed-meshheading:21353569-Isomerism,
pubmed-meshheading:21353569-Pyrazoles,
pubmed-meshheading:21353569-Structure-Activity Relationship,
pubmed-meshheading:21353569-Xanthine Oxidase
|
pubmed:year |
2011
|
pubmed:articleTitle |
A rational approach for the design and synthesis of 1-acetyl-3,5-diaryl-4,5-dihydro(1H)pyrazoles as a new class of potential non-purine xanthine oxidase inhibitors.
|
pubmed:affiliation |
Laboratory for Drug Design and Synthesis, Department of Pharmaceutical Chemistry, Indo-Soviet Friendship College of Pharmacy, Moga-142 001, Punjab, India.
|
pubmed:publicationType |
Journal Article
|